TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development ...

Pharma stock Theralase Technologies (TSXV:TLT) announced a significant update on its ongoing bladder cancer clinical study ...

Prostate cancer is a major health concern for men worldwide — often developing without any immediate warning signs. Catching ...

Northwestern raised a record $1.05 billion in research funding this fiscal year, a 5% increase since 2023. The Daily compiled ...

Enfortumab vedotin plus pembrolizumab was previously granted a priority review designation from the MHLW.

Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. September 24, 2024 Comparative Effectiveness of Bacillus Calmette-Guérin and ...

Prostate cancer is a major health concern in Louisiana, where it is the second leading cause of cancer death in men. Of every ...

In many cases, prostate cancer doesn’t cause any symptoms at all. The best way of detecting prostate cancer early is with a ...

However, women are far less likely to be diagnosed with bladder cancer than men, with men over the age of 85 most at risk. The greatest risk factors for the disease are smoking, and long-term ...

Bladder cancer is a type of cancer called carcinoma that most often occurs in the inner lining of the bladder. The disease is caused by abnormal cellular growth leading to a malignant tumor. The most ...

Prostate cancer screening can help detect signs of cancer before symptoms start. It’s essential for men to talk with their ...